[1]
Neumann FJ, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J 2018.
[2]
Stone GW, Sabik JF, Serruys PW, et al. Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease. N Engl J Med 2016; 375: 2223-35.
[3]
Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 2009; 360: 961-72.
[4]
Fearon WF, Zimmermann FM, De Bruyne B, et al. Fractional Flow Reserve-Guided PCI as Compared with Coronary Bypass Surgery. N Engl J Med 2022; 386: 128-37.
[5]
Escaned J, Collet C, Ryan N, et al. Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study. Eur Heart J 2017; 38: 3124-34.
[6]
Wolfrum M, De Maria GL, Benenati S, et al. What are the causes of a suboptimal FFR after coronary stent deployment? Insights from a consecutive series using OCT imaging. EuroIntervention 2018; 14: e1324-31.
[7]
Marin F, Scarsini R, Terentes-Printzios D, et al. The role of coronary physiology in contemporary percutaneous coronary interventions. Curr Cardiol Rev 2021.
[8]
Alkhalil M, McCune C, McClenaghan L, et al. Clinical Outcomes of Deferred Revascularisation Using Fractional Flow Reserve in Diabetic Patients. Cardiovasc Revasc Med 2020; 21: 897-902.
[9]
Alkhalil M, McCune C, McClenaghan L, et al. Comparative Analysis of the Effect of Renal Function on the Spectrum of Coronary Artery Disease. Am J Med 2020; 133: e631-40.
[10]
Alkhalil M, Thomas G, Spence MS, Owens C, McKavanagh P. Sex-based difference in fractional flow reserve and its impact on clinical outcomes. Am Heart J 2021; 242: 24-32.
[12]
Zaidan M, Alkhalil M, Alaswad K. Calcium Modifications Therapies in Contemporary Percutaneous Coronary Intervention. Curr Cardiol Rev 2021.
[13]
Wu EB, Brilakis ES, Mashayekhi K, et al. Global Chronic Total Occlusion Crossing Algorithm: JACC State-of-the-Art Review. J Am Coll Cardiol 2021; 78: 840-53.
[14]
Kawashima H, Serruys PW, Hara H, et al. 10-Year All-Cause Mortality Following Percutaneous or Surgical Revascularization in Patients With Heavy Calcification. JACC Cardiovasc Interv 2022; 15: 193-204.
[15]
Hill JM, Kereiakes DJ, Shlofmitz RA, et al. Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Artery Disease. J Am Coll Cardiol 2020; 76: 2635-46.
[16]
Mailey JA, Spence MS. The Contemporary Management of Left Main Coronary Artery Disease. Curr Cardiol Rev 2021.
[17]
Sabatine MS, Bergmark BA, Murphy SA, et al. Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta-analysis. Lancet 2021; 398: 2247-57.
[18]
Alkhalil M. Mechanistic Insights to Target Atherosclerosis Residual Risk. Curr Probl Cardiol 2021; 46100432
[19]
Alkhalil M. Novel tools for new therapies in the era of contemporary percutaneous coronary revascularisation. Curr Cardiol Rev 2021.
[20]
Reinstadler SJ, Stiermaier T, Liebetrau J, et al. Prognostic Significance of Remote Myocardium Alterations Assessed by Quantitative Noncontrast T1 Mapping in ST-Segment Elevation Myocardial Infarction. JACC Cardiovasc Imaging 2018; 11: 411-9.
[21]
De Maria GL, Alkhalil M, Borlotti A, et al. Index of microcirculatory resistance-guided therapy with pressure-controlled intermittent coronary sinus occlusion improves coronary microvascular function and reduces infarct size in patients with ST-elevation myocardial infarction: the Oxford Acute Myocardial Infarction - Pressure-controlled Intermittent Coronary Sinus Occlusion study (OxAMI-PICSO study). EuroIntervention 2018; 14: e352-9.
[22]
De Maria GL, Alkhalil M, Wolfrum M, et al. Index of Microcirculatory Resistance as a Tool to Characterize Microvascular Obstruction and to Predict Infarct Size Regression in Patients With STEMI Undergoing Primary PCI. JACC Cardiovasc Imaging 2019; 12: 837-48.
[23]
De Maria GL, Fahrni G, Alkhalil M, et al. A tool for predicting the outcome of reperfusion in ST-elevation myocardial infarction using age, thrombotic burden and index of microcirculatory resistance (ATI score). EuroIntervention 2016; 12: 1223-30.
[24]
De Maria GL, Lee R, Alkhalil M, et al. Reflectance spectral analysis for novel characterization and clinical assessment of aspirated coronary thrombi in patients with ST elevation myocardial infarction. Physiol Meas 2020; 41045001
[25]
Fahrni G, Wolfrum M, De Maria GL, et al. Index of Microcirculatory Resistance at the Time of Primary Percutaneous Coronary Intervention Predicts Early Cardiac Complications: Insights From the OxAMI (Oxford Study in Acute Myocardial Infarction). Cohort. J Am Heart Assoc 2017; p. 6.
[26]
De Maria GL, Alkhalil M, Wolfrum M, et al. The ATI score (age-thrombus burden-index of microcirculatory resistance) determined during primary percutaneous coronary intervention predicts final infarct size in patients with ST-elevation myocardial infarction: a cardiac magnetic resonance validation study. EuroIntervention 2017; 13: 935-43.
Article Metrics
9
1